ELKAR SOLUTION FOR INTERNAL USE 30% BOTTLE 100ML

Release form

Oral solution

Packaging

Bottle of 100 ml.

pharmachologic effect

Elkar contains L-carnitine. L-carnitine is a natural substance related to group B Vitamins. It participates in metabolic processes as a carrier of long-chain fatty acids (palmitic, etc.) from the cytoplasm to the mitochondria, where these acids undergo the β-oxidation process with the formation of adenosine triphosphate acid and acetyl-CoA.
It improves protein and fat metabolism, increases the secretion and enzymatic activity of the gastric and intestinal juices, improves the absorption of food, reduces overweight and reduces the fat content in muscles. Increases resistance to physical stress, inhibits the formation of keto acids and anaerobic glycolysis, reduces the degree of lactic acidosis, contributes to the economical expenditure of glycogen and increases its reserves in the liver and muscles.
It has anabolic and lipolytic effects. Normalizes increased basal metabolism in hyperthyroidism: it is a peripheral (indirect) antagonist of thyroid hormone action, and not a direct inhibitor of thyroid function. Improves metabolism and energy supply of tissues.

Indications

The drug is used as part of complex therapy for:
- Intensive physical exertion and psychoemotional exertion: to improve performance, endurance, reduce fatigue, including in the elderly.
- During the period of rehabilitation after illness and surgery, injuries, including to accelerate tissue regeneration.
- Therapy of chronic gastritis and chronic pancreatitis with reduced secretory function.
- Therapy of skin diseases (psoriasis, seborrheic eczema, focal scleroderma and discoid lupus erythematosus).
- Hyperthyroidism mild.
- Neurological manifestations in vascular, toxic and traumatic brain lesions.
- Syndrome of anorexia nervosa.
- Diseases accompanied by a lack of Carnitine or its increased loss (myopathy, cardiomyopathy, mitochondrial diseases, hereditary diseases with concomitant mitochondrial insufficiency) - to compensate for its deficiency.
- In pediatric practice (treatment of children under 3 years of age under the supervision of a physician): when nursing premature babies, newborns who have suffered a birth trauma or asphyxia; children with a sluggish sucking reflex and low weight gain; children with reduced muscle tone, with insufficient development of motor and mental functions, as well as to prevent these disorders in children at risk; with stunting and underweight in children and adolescents under 16 years of age.
- In adults, in sports medicine and during intensive training (during the training process during the development of aerobic performance): to improve speed-strength performance and coordination of movements; to increase muscle mass and reduce fat mass; for the prevention of post-training syndrome (acceleration of recovery processes after exercise); with traumatic injuries in order to accelerate muscle regeneration.

Contraindications

Individual intolerance.

Use during pregnancy and lactation

Use during pregnancy is contraindicated due to lack of research. It is necessary to stop breastfeeding during the period of use of the drug.

Dosage and administration

The drug is used as part of complex therapy. Inside for 30 minutes before eating, further diluting with liquid.
With prolonged physical and psycho-emotional stress: from 0.75 g (1/2 measuring spoon or 2.5 ml) 3 times a day to 2.25 g (1.5 measuring spoons or 7.5 ml) 2-3 times a day.
In anorexia nervosa, as well as during the rehabilitation period after illness and surgery and injuries: on 1,5 g (1 measured spoon or 5 ml) 2 times a day. The course of treatment is within 1-2 months.
In the complex therapy of chronic gastritis and chronic pancreatitis with reduced secretory function: 0.375 g (1/4 scoop or 1.25 ml) 2 times a day. The course of treatment is within 1-1.5 months.
For the treatment of skin diseases: at 0.75 g (1/2 scoop or 2.5 ml). The course of treatment is within 2-4 weeks.
In mild hyperthyroidism: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break or is prescribed for 3 months without a break.
With vascular, toxic and traumatic brain lesions: 0.75 g (1/2 scoop or 2.5 ml) per day. The course of treatment is within 3-5 days. If necessary, after 12-14 days appoint a second course.
For diseases accompanied by a lack of carnitine (primary and secondary carnitine deficiency): up to 50-100 mg / kg (2-5 drops / kg) of body weight with a frequency of taking 2-3 times a day. The course of treatment is within 3-4 months.
Children are prescribed as an additive to sweet dishes (kissel, compote, juices): children up to 3 years, the dose is determined by the attending physician; from 3 to 6 years - in a single dose of 0.1 g (5 drops) 2-3 times a day, in a daily dose of 0.2-0.3 g (11-16 drops). The course of treatment is 1 month; children from 6 to 12 years old are prescribed in a single dose of 0.2-0.3 g (11-16 drops) 2-3 times a day, in a daily dose of 0.4-0.9 g (22-48 drops). The course of treatment is at least 1 month.
With stunted growth: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break or is prescribed for 3 months without a break.
In sports medicine and with intense workouts: 2.5 g 1-3 times a day (daily dose of 2.5-7.5 g). In the case of use for therapeutic purposes - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the precompetitive period. During the training process - up to 6-8 weeks.

Side effects

Possible: allergic reactions, gastralgia, dyspepsia, myasthenia gravis (in patients with uremia).

special instructions

Treatment of children under the age of 3 years under the supervision of a physician.
Influence on ability to drive motor transport and control mechanisms: the drug does not affect the performance of potentially hazardous activities that require special attention and quick reactions (driving and other vehicles, working with moving machinery, the work of the dispatcher and operator, etc.)

Drug interaction

Glucocorticosteroids contribute to the accumulation of the drug in the tissues (except the liver), other anabolics enhance the effect.

Overdose

Symptoms: dyspeptic disorders, myasthenic disorders (in patients with uremia).
Treatment: gastric lavage, reception of Activated carbon.

Storage conditions
Store in a dark place at a temperature of from 15 to 25 ° C.